Drug identification & validation in physiological environment, #PrecisionMedicine and #PatientStratification Interactome & pathway elucidation of drug targets" title="" class="btn" data-container="body" data-html="true" data-id="139966" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Inoviem Scientific"> 89 4,506
Activities
Technologies
Entity types
Location
850 Bd Sébastien Brant, 67400 Illkirch-Graffenstaden CEDEX, France
Illkirch-Graffenstaden
France
Employees
Scale: 11-50
Estimated: 8
SIREN
535375588Engaged catalyst
2Added in Motherbase
4 years, 2 months agoCreative Technologies for Efficient Therapeutics, Precision medicine
Inoviem Scientific is a private Bioanalytical company which delivers enabling information to secure drug discovery programs and to take informed decision by closing the gap between preclinical and clinical development. We reconcile translational pharmacology and human physiology by using fresh patient material from the target cohort, embracing the complexity of human diseases.
Inoviem's enabling technologies are working in pathological conditions to get the treatment in development to the right patient.
Our indication-agnostic access to patients combined with innovative label-free platforms deliver Target identification and validation, targets & Mode of Action deconvolution, patient stratification, predictive biomarkers and companion test to unlock the potential of any program in development.
We believe science is truly meaningful when it directly or indirectly serves living beings. Our mission is to improve patients' lives by accelerating the development of more effective, precise and safer medicines through our scientific endeavors.
Patient stratification, Target identification, Label-free technologies, Mechanism of action elucidation, Predictive biomarker identification, OFF target identification, Target deconvolution, Pharmacology, Protein interactions, Target Validation, Drug Development, Drug Discovery, Preclinical, Clinical Development, Target Engagament, Patients, Translational Science, Translational Medicine, Ex-vivo, Drug Repositioning , drug upgrade, and Compound screening
Creative Technologies for Efficient Therapeutics, Precision medicine
Inoviem Scientific is a private Bioanalytical company which delivers enabling information to secure drug discovery programs and to take informed decision by closing the gap between preclinical and clinical development. We reconcile translational pharmacology and human physiology by using fresh patient material from the target cohort, embracing the complexity of human diseases.
Inoviem's enabling technologies are working in pathological conditions to get the treatment in development to the right patient.
Our indication-agnostic access to patients combined with innovative label-free platforms deliver Target identification and validation, targets & Mode of Action deconvolution, patient stratification, predictive biomarkers and companion test to unlock the potential of any program in development.
We believe science is truly meaningful when it directly or indirectly serves living beings. Our mission is to improve patients' lives by accelerating the development of more effective, precise and safer medicines through our scientific endeavors.
Our groundbreaking label-free technologies enable you to detect and identify the clinical power of, and weaknesses in, your compound from early-stage pre-clinical R&D through to clinical trials
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 25 Feb 2025 | | |
![]() Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 25 Feb 2025 | |